Live Quote · NASDAQVBIVHealthcare· Biotechnology

VBI Vaccines Inc.

$0.07 50.87%($-0.07)
TickerSpark Score
57/100
Mixed
73
Valuation
40
Profitability
100
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VBIV research report →

52-Week Range1% of range
Low
$0.06
Current
$0.07
High
$1.35
Company Overviewwww.vbivaccines.com

About the company

VBI Vaccines Inc. is a biopharmaceutical firm dedicated to the development and commercialization of vaccines, targeting both infectious diseases and immuno-oncology. Among its commercial offerings is Sci-B-Vac, a prophylactic vaccine designed to prevent hepatitis B (HBV).

CEO
Jeffery R. Baxter FCMA
IPO
2010
Employees
131
HQ
Cambridge, MA, US

Price Chart

-98.39% · this period
$1.24$0.63$0.02Sep 05Mar 06Sep 04
Valuation
Market Cap
$1.87M
P/E
-0.01
P/S
0.22
P/B
0.14
EV/EBITDA
-0.38
Div Yield
0.00%
Profitability
Gross Margin
-66.98%
Op Margin
-637.08%
Net Margin
-1069.29%
ROE
-258.99%
ROIC
-86.51%
Growth & Income
Revenue
$8.68M · 702.40%
Net Income
$-92,836,000 · 34.14%
EPS
$-5.96 · 63.59%
Op Income
$-55,311,000
FCF YoY
20.87%
Performance & Tape
52W High
$1.35
52W Low
$0.06
50D MA
$0.57
200D MA
$0.60
Beta
2.17
Avg Volume
8.39M

Get TickerSpark's AI analysis on VBIV

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 27, 23DeWilde Michelother35,000
Jul 27, 23Braga Damianother35,000
Jul 27, 23Baxter Jeffother70,000
Jul 27, 23Cordeiro Joanneother35,000
Jul 27, 23Beattie Nellother52,500
Jul 27, 23HIMES VAUGHN Bother35,000
Jul 27, 23Mazaltov Aviother52,500
Jul 27, 23Diaz-Mitoma Franciscoother52,500
Jul 27, 23GILLIS STEVENother52,500
Jul 27, 23Dillman John Robertother52,500
Coverage · VBIV

Our VBIV coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VBIV yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VBIV report →
Internal Compare

Similar companies

Peers in the same neighborhood.